In the TWM cases, except case 1, ARID3A [35], ASXL1 [36], ASXL2 [36], FMN2 [37], FAM83B [38] and ZFHX4 [39] mutations were also identified as potential oncogenic drivers, known from other tumor types. This evidence concerns the gene ZFHX4 and neoplasm.